These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10615894)

  • 21. Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice.
    Djogo N; Jakovcevski I; Müller C; Lee HJ; Xu JC; Jakovcevski M; Kügler S; Loers G; Schachner M
    Neurobiol Dis; 2013 Aug; 56():104-15. PubMed ID: 23639788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipofuscin and Abeta42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains.
    D'Andrea MR; Nagele RG; Gumula NA; Reiser PA; Polkovitch DA; Hertzog BM; Andrade-Gordon P
    Neurosci Lett; 2002 Apr; 323(1):45-9. PubMed ID: 11911987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
    Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
    Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of Abeta42 and Alzheimer's disease neuropathology.
    Hashimoto M; Bogdanovic N; Volkmann I; Aoki M; Winblad B; Tjernberg LO
    Acta Neuropathol; 2010 May; 119(5):543-54. PubMed ID: 20198479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
    Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amyloid (senile) plaques in Alzheimer's disease brain].
    Ishii T
    Nihon Rinsho; 1991 Apr; 49(4):945-9. PubMed ID: 1906554
    [No Abstract]   [Full Text] [Related]  

  • 27. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
    Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
    Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
    Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid (Abeta) deposition in chromosome 1-linked Alzheimer's disease: the Volga German families.
    Mann DM; Iwatsubo T; Nochlin D; Sumi SM; Levy-Lahad E; Bird TD
    Ann Neurol; 1997 Jan; 41(1):52-7. PubMed ID: 9005865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
    Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histochemistry and immunohistochemistry of Alzheimer's disease.
    Ulrich J
    Prog Histochem Cytochem; 1993; 27(1):1-63. PubMed ID: 7690493
    [No Abstract]   [Full Text] [Related]  

  • 33. Alzheimer's debate boils over.
    Marx J
    Science; 1992 Sep; 257(5075):1336-8. PubMed ID: 1529329
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mitochondrial dysfunction and neuronal apoptosis: new molecular approach to prevent Alzheimer's disease].
    Takuma K; Kataoka S; Ago Y; Matsuda T
    Nihon Yakurigaku Zasshi; 2009 Oct; 134(4):180-3. PubMed ID: 19828920
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent research on the causes of Alzheimer's disease.
    Rowan MJ
    Proc Nutr Soc; 1993 Feb; 52(1):255-62. PubMed ID: 8493271
    [No Abstract]   [Full Text] [Related]  

  • 36. Alzheimer's disease.
    Br Med J; 1980 Nov; 281(6252):1374-5. PubMed ID: 6108151
    [No Abstract]   [Full Text] [Related]  

  • 37. Possible role of apoptosis in Alzheimer's disease.
    Cotman CW; Whittemore ER; Watt JA; Anderson AJ; Loo DT
    Ann N Y Acad Sci; 1994 Dec; 747():36-49. PubMed ID: 7847684
    [No Abstract]   [Full Text] [Related]  

  • 38. Microbes and Alzheimer's Disease.
    Itzhaki RF; Lathe R; Balin BJ; Ball MJ; Bearer EL; Braak H; Bullido MJ; Carter C; Clerici M; Cosby SL; Del Tredici K; Field H; Fulop T; Grassi C; Griffin WS; Haas J; Hudson AP; Kamer AR; Kell DB; Licastro F; Letenneur L; Lövheim H; Mancuso R; Miklossy J; Otth C; Palamara AT; Perry G; Preston C; Pretorius E; Strandberg T; Tabet N; Taylor-Robinson SD; Whittum-Hudson JA
    J Alzheimers Dis; 2016; 51(4):979-84. PubMed ID: 26967229
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent progress in the characterization of the pathological hallmarks for Alzheimer's disease.
    Ulrich J
    Acta Neurol Scand Suppl; 1990; 129():5-7. PubMed ID: 2220325
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences between early and late-onset Alzheimer's disease.
    Iversen LL
    Neurobiol Aging; 1987; 8(6):554-5. PubMed ID: 3431630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.